Lazard Asset Management
VERV

Lazard Asset Management’s Verve Therapeutics VERV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-85
Closed 2593
2024
Q4
$0 Hold
85
﹤0.01% 2555
2024
Q3
$0 Sell
85
-56
-40% ﹤0.01% 2468
2024
Q2
$0 Sell
141
-3,899
-97% ﹤0.01% 2440
2024
Q1
$52K Sell
4,040
-751
-16% -$9.67K ﹤0.01% 1709
2023
Q4
$65K Buy
4,791
+2,776
+138% +$37.7K ﹤0.01% 1823
2023
Q3
$26K Buy
2,015
+89
+5% +$1.15K ﹤0.01% 2059
2023
Q2
$35K Buy
1,926
+55
+3% +$999 ﹤0.01% 1942
2023
Q1
$26K Buy
1,871
+396
+27% +$5.5K ﹤0.01% 1992
2022
Q4
$27K Sell
1,475
-404
-22% -$7.4K ﹤0.01% 2077
2022
Q3
$64K Buy
+1,879
New +$64K ﹤0.01% 1686